Repligen (RGEN) Invested Capital (2013 - 2026)

Repligen (RGEN) has reported Invested Capital for 9 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Invested Capital fell 41.47% year-over-year to $3.0 million; the TTM figure through Jun 2026 stood at $18.4 million (down 97.19% YoY), while the FY2025 annual figure was $5.0 million, down 70.52% from the prior year.
• Invested Capital declined to $3.0 million in Q2 2026 per RGEN's latest filing, from $5.2 million in the prior quarter.
• Across five years, Invested Capital topped out at $600.0 million in Q4 2023 and bottomed at $3.0 million in Q2 2026.
• Historically, Invested Capital has averaged $144.6 million across 5 years, with a median of $16.7 million in 2022.
• Annual changes were most pronounced in 2024 — Invested Capital soared 4666.07% — and 2025, when it tumbled 99.15%.
• Repligen's Invested Capital stood at $14.0 million in 2022, then surged by 4201.08% to $600.0 million in 2023, then tumbled by 97.15% to $17.1 million in 2024, then sank by 70.52% to $5.0 million in 2025, then tumbled by 40.09% to $3.0 million in 2026.
• Business Quant data shows RGEN's Invested Capital at $3.0 million in Q2 2026, $5.2 million in Q1 2026, and $5.0 million in Q4 2025.